What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
No abstract is available for this item.
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Kane, Nancy M. & Saltman, Richard B., 1997. "Comparative experience in home care and pharmaceutical policy," Health Policy, Elsevier, vol. 41(Supplemen), pages S1-S7, September.
- Ljungkvist, Mats-Olof & Andersson, David & Gunnarsson, Bo, 1997. "Cost and utilisation of pharmaceuticals in Sweden," Health Policy, Elsevier, vol. 41(Supplemen), pages S55-S69, September.
- Kane, Nancy M., 1997. "Pharmaceutical cost containment and innovation in the United States," Health Policy, Elsevier, vol. 41(Supplemen), pages S71-S89, September.
- Abel-Smith, Brian & Mossialos, Elias, 1994. "Cost containment and health care reform: a study of the European Union," Health Policy, Elsevier, vol. 28(2), pages 89-132, May.
When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:44:y:1998:i:3:p:253-260. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Shamier, Wendy)or ()
If references are entirely missing, you can add them using this form.